DETECT Study Aims to Identify Asymptomatic Atherosclerosis Prevalence and Risk Factors
The DETECT study aims to determine the prevalence of silent atherosclerosis in adults and identify risk factors for subclinical atherosclerosis.
Phase III
Cardiovascular / Atherosclerosis
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The DETECT study aims to redefine screening and prevention strategies for silent atherosclerosis, which could significantly impact cardiovascular care. Its findings may lead to more targeted interventions, influencing market dynamics and competitive positioning in the cardiovascular sector.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor results from the DETECT study and subsequent phases for insights on risk factors and screening methodologies.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.